日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acoustic Radiation Force Impulse Elastographic Study of Lung Lesions in Dogs

犬肺部病变的声辐射力脉冲弹性成像研究

Lima, Bruna Bressianini; Carneiro, Rafael Kretzer; Miranda, Brenda Santos Pompeu; Gasser, Beatriz; Aires, Luiz Paulo Nogueira; Terrabuio, Verônica Maria Teixeira de Castro; Uscategui, Ricardo Andrés Ramirez; Junior, Antônio Carlos Cunha Lacreta; Doiche, Danuta Pulz; Evangelista, Gabriela Castro Lopes; Feliciano, Marcus Antônio Rossi

Histopathological, immunohistochemical and imaging features of bone metastases of mammary carcinoma in bitches: cases report

母犬乳腺癌骨转移的组织病理学、免疫组织化学和影像学特征:病例报告

Garcia, Ana Paula Vargas; Souza, Fernanda Rezende; Telles, Luiz Flávio; Lacreta, Antônio Carlos; Varaschin, Mary Suzan; Cassali, Geovanni Dantas

Pathological fracture induced by Halicephalobus gingivalis (Nematoda: Rhabditida) in a horse limb

马肢骨因牙龈哈利氏线虫(线虫纲:杆状目)引起的病理性骨折

Sousa, Ticiana Meireles; Toma, Hugo Shisei; Lima, Antonio de Pádua; Junior, Antonio Carlos Cunha Lacreta; Nunes, Maira Meira; Silva, Ana Paula Cassiano da; Wouters, Daniel; Albuquerque, Adriana Silva; Varaschin, Mary Suzan; Raymundo, Djeison Lutier; Toma, Claudia Dias Monteiro; Batista, Fernando Arévalo

Pharmacokinetics of the Multi-kinase Inhibitor Pexidartinib: Mass Balance and Dose Proportionality

多激酶抑制剂佩西达替尼的药代动力学:质量平衡和剂量比例

Zahir, Hamim; Greenberg, Jonathan; Hsu, Ching; Watanabe, Kengo; Makino, Chie; He, Ling; LaCreta, Frank

Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects

评估Pexidartinib在健康受试者中的吸收和代谢相关的药物相互作用潜力

Zahir, Hamim; Greenberg, Jonathan; Shuster, Dale; Hsu, Ching; Watanabe, Kengo; LaCreta, Frank

Effect of Mild and Moderate Hepatic Impairment (Defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics

轻度至中度肝功能损害(根据 Child-Pugh 分级和美国国家癌症研究所器官功能障碍工作组标准定义)对 Pexidartinib 药代动力学的影响

Zahir, Hamim; Greenberg, Jonathan; Hsu, Ching; Marbury, Thomas C; Lasseter, Kenneth C; Xu, Li-An; Tap, William D; Healey, John H; Stacchiotti, Silvia; LaCreta, Frank

Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2-Positive Breast Cancer and Other Solid Tumors

曲妥珠单抗德鲁替康在HER2阳性乳腺癌和其他实体瘤患者中的群体药代动力学

Yin, Ophelia; Xiong, Yuan; Endo, Seiko; Yoshihara, Kazutaka; Garimella, Tushar; AbuTarif, Malaz; Wada, Russ; LaCreta, Frank

Menadione reduces CDC25B expression and promotes tumor shrinkage in gastric cancer

甲萘醌降低CDC25B表达并促进胃癌肿瘤缩小

Amanda Braga Bona, Danielle Queiroz Calcagno, Helem Ferreira Ribeiro, José Augusto Pereira Carneiro Muniz, Giovanny Rebouças Pinto, Carlos Alberto Machado Rocha, Antonio Carlos Cunha Lacreta Junior, Paulo Pimentel de Assumpção, Juan Antonio Rey Herranz, Rommel Rodriguez Burbano

Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review

纯红细胞再生障碍性贫血及血液透析患者抗促红细胞生成素抗体:两例病例报告及文献综述

Lacreta, Gabriela; Bucharles, Sérgio Gardano Elias; Sevignani, Gabriela; Riella, Miguel Carlos; Nascimento, Marcelo Mazza do

First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects

首次人体研究,旨在评估BMS-962212(一种直接、可逆的小分子因子XIa抑制剂)在非日本籍和日本籍健康受试者中的安全性、药代动力学和药效学。

Perera, Vidya; Luettgen, Joseph M; Wang, Zhaoqing; Frost, Charles E; Yones, Cynthia; Russo, Cesare; Lee, John; Zhao, Yue; LaCreta, Frank P; Ma, Xuewen; Knabb, Robert M; Seiffert, Dietmar; DeSouza, Mary; Mugnier, Pierre; Cirincione, Brenda; Ueno, Takayo; Frost, Robert J A